Graeme Moffat

Here’s a discussion I had with Daniel Lee, the compelling founder of OMD Ventures. Podcast: https://share.transistor.fm/e/1f183d3d

No. It’s not all nonsense, but some of it definitely is. This article from Diana Kwon does a good job of discussing some of the industry’s challenges (with a quote from yours truly).

Chris Aimone and I were fortunate to be given the opportunity to present from the Digital Health Summit stage at CES 2019. Here’s what we said.

These remarks were delivered to the OECD Working Group on Emerging Technologies Minding Neurotechnology Workshop, Shanghai, China, September 6, 2018

Continue reading “What should be the priorities of the neurotechnology sector?”

In putting together the article above, Christina Farr was gracious enough to listen to my theory about Apple’s not-so-secret plan that explains why there’s suddenly an ECG in the Apple Watch 4. What surprised me the most is that everyone focused on it as an ECG, including all of the tech and digital health press, and missed Apple’s brilliant, extremely broad patent from 2014.

Continue reading “Hardware, software, data, and how Apple’s control of all three defines the future of digital health”

As part of the Ontario360 30-on-30 initiative organized by Sean Speer at the Munk School of Public Policy, creative policy suggestions (proposed as non-partisan transition briefings for Ontario’s new government, just before the election) were solicited on how to solve some of the province’s toughest challenges. Here’s my contribution on economic development, R&D, and innovation.

A few weeks ago, Neil Desai and I took issue with the feel-good narrative about growth in Canadian tech and innovation in The Globe and Mail. You can read our piece here.

https://www.youtube.com/watch?v=Rj1QvvSdL2Y

I really enjoyed giving this talk, on neurotechnology as a career and how to move from academic science into business, at Brainhack Toronto.